Clinical trials
Active, not recruiting Phase 1 Carcinoma, Hepatocellular trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| City of Hope Medical Center | 3 |
| AbbVie | 2 |
| Jonsson Comprehensive Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Baylor College of Medicine | 1 |
| Beijing Gene Key Life Technology Co., Ltd | 1 |
| Chugai Pharmaceutical | 1 |
| Eisai Co., Ltd. | 1 |
| Eisai Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 28 |
| Ovarian Neoplasms | 5 |
| Triple Negative Breast Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
| Carcinoma, Transitional Cell | 4 |
| Cholangiocarcinoma | 4 |
| Colorectal Neoplasms | 4 |
| Liver Neoplasms | 4 |
| Pancreatic Neoplasms | 4 |
| Urinary Bladder Neoplasms | 4 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.